捷昌驅動(603583.SH):“領雁”研發攻關計劃項目目前尚未對市場進行批量供貨,暫未形成收入
格隆匯3月5日丨捷昌驅動(603583.SH)公佈,公司關注到近期市場對於人形機器人相關概念的關注度較高,部分機構將公司列為機器人概念標的。公司就相關事項澄清説明如下:公司專注於線性驅動行業,公司生產的線性驅動系統可廣泛應用於智慧辦公、醫療康護、智能家居等領域。公司主持的“領雁”研發攻關計劃項目-高推力密度電動線性致動器關鍵技術研究仍處於研發和測試階段,目前尚未對市場進行批量供貨,暫未形成收入,如後續有重大進展,公司將及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.